Skip To Main Content
Lauren Dembeck on Muck Rack

Lauren Dembeck

As seen in: PLOS, The Clinical Advisor, ONCOLOGY journal, Monthly Prescribing Reference, Cancer Therapy Advisor, Psychiatry Advisor, Renal & Urology News, Infectious Disease Advisor, Neurology Advisor, Endocrinology Advisor and
Freelance science & medical writer: genetics/genomics, neurobiology, hematology/oncology, medical oncology, pediatrics, and more

Get in touch with Lauren

Contact Lauren, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Urine Tumor DNA May Forecast Recurrence Risk After BCG in High-Risk NMIBC

|
By Lauren Dembeck
| Cancer Therapy Advisor Verified
Urine tumor DNA (utDNA) testing may identify patients with high-risk non-muscle-invasive bladder cancer (NMIBC) at increased risk for recurrence following bacillus Calmette-Guérin (BCG) therapy even sooner than standard surveillance, a study suggests. Current surveillance relies primarily on cystoscopy and urine cytology after intravesical BCG therapy, which may miss occult disease.
Open in Who Shared Issue with article?

Corneal Changes After SLT Are Rare, May Be Influenced By Patient Factors

|
By Lauren Dembeck
| optometryadvisor.com
Corneal edema and thinning after selective laser trabeculoplasty (SLT) are rare complications, occurring in approximately 1 in 1350 adults; however, men and patients with myopia may be at higher risk for developing post-SLT corneal changes, according to findings published in Ophthalmology Glaucoma.
Open in Who Shared Issue with article?

Urine Tumor DNA May Forecast Recurrence Risk After BCG in High-Risk NMIBC

|
By Lauren Dembeck
| Renal & Urology News Verified
Urine tumor DNA (utDNA) testing may identify patients with high-risk non-muscle-invasive bladder cancer (NMIBC) at increased risk for recurrence following bacillus Calmette-Guérin (BCG) therapy even sooner than standard surveillance, a study suggests. Current surveillance relies primarily on cystoscopy and urine cytology after intravesical BCG therapy, which may miss occult disease.
Open in Who Shared Issue with article?
See all 937 licensed articles (942 Total)